If you are unable to locate a specific product please contact us.                    Looking for Certificates of Analysis (COA)? Search certificates here.                    Improve lives while advancing your career. Search our latest openings.                   
Tokyo Stock Exchange Listing Press Release | Epredia
Close
Close Choose language
Select

Announcement of Approval for Listing of Shares of PHC Holdings Corporation on the Tokyo Stock Exchange

September 7, 2021

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: John Marotta) has today announced the approval by Tokyo Stock Exchange, Inc. (the “TSE”) for the listing of the shares of its common stock (the “shares”) on the First Section of TSE. The scheduled date for the listing of the shares is Thursday October 14, 2021, on or after which date the shares will be available for trading on the TSE.

IMPORTANT NOTICE:
This document is a press release prepared for the sole purpose of public announcement and is not prepared for the purpose of soliciting investment or engaging in any other similar activities thereto, whether within or outside Japan. In the event of making an investment in Japan, please carefully review the prospectus (including any amendments thereto) prepared by us and make an independent investment decision.

In addition, this press release is not an offer of securities for sale in the United States. The shares may not be offered or sold in the United States absent registration or an exemption from requirement. If any public offering of the shares is made in the United States, it will be by means of a prospectus that may be obtained from us or the selling shareholders and that will contain detailed information about us and our management, as well as our financial statements.

About Epredia

Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics. Powered by key brands, including Erie Scientific, Menzel-Gläser, Microm, Shandon, and Richard-Allan Scientific, Epredia’s portfolio includes microscope slides, instruments and consumables. Epredia was established following the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business by PHC Holdings in 2019. Epredia has major sites in the United States, the United Kingdom, Germany, Switzerland and China with a total of around 1,200 employees. Epredia is committed to achieving its mission to improve lives by enhancing cancer diagnostics for patients around the world. For further information on Epredia and its products, please visit www.epredia.com.

About PHC Holdings Corporation

Company Name: PHC Holdings Corporation
Representative: President, CEO John Marotta
Incorporation: March 31, 2014
Headquarters: 2-38-5 Nishishimbashi, Minato-ku, Tokyo, Japan
www.phchd.com

For more information, please contact:

Epredia Media:

Joseph Delahunty

PHC Group, Corporate Communications

Email: moc.aisnecsa%%%%ytnuhaled.hpesoj

PHC Holdings Corporation Media:

PHC Holdings Corporation
Corporate Planning Department

Email: moc.dhchp.gg%%%%pc-chp

You are leaving the full Epredia.com website. You will be redirected to the [language] site with limited information on our solutions for your laboratory. For more information please fill out the 'contact us' form and a sales representative will answer all of your questions.

Go Back
Continue

您將離開 Epredia.com 日語網站。 您將被重定向到 [language] 有關實驗室解決方案的信息有限的站點。如需更多信息,請填寫聯繫表格。銷售代表將回答您的所有問題。

后退
继续

Sie verlassen die deutsche Website von Epredia.com. Sie werden auf die [language]-Website mit eingeschränkten Informationen zu unseren Lösungen für Ihr Labor weitergeleitet. Für weitere Informationen füllen Sie bitte das Kontaktformular aus und ein Vertriebsmitarbeiter wird alle Ihre Fragen beantworten.

Geh zurück
Weitermachen

Vous quittez le site complet Epredia.com. Vous serez redirigé vers le site [language] avec des informations limitées sur nos solutions pour votre laboratoire. Pour plus d'informations, veuillez remplir le formulaire "nous contacter" et un représentant des ventes répondra à toutes vos questions.

Retourner
Continuer

Stai uscendo dal sito Epredia.com completo. Verrai reindirizzato al sito [language] con informazioni limitate sulle nostre soluzioni per il tuo laboratorio. Per ulteriori informazioni, compila il modulo "contattaci" e un rappresentante commerciale risponderà a tutte le tue domande.

Restituzione
Continua

Está saliendo del sitio completo de Epredia.com. Será redirigido al sitio [language] con información limitada sobre nuestras soluciones para su laboratorio. Para obtener más información, complete el formulario "Contáctenos" y un representante de ventas responderá todas sus preguntas.

Devolver
Continua